Loading...
Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma
Improved knowledge about the pathogenesis of asthma has facilitated the development of novel drugs and provided hope for patients with severe asthma. After the short- and long-term success of omalizumab in severe allergic phenotype, researchers have targeted patients with severe eosinophilic asthma...
Na minha lista:
| Udgivet i: | Turk Thorac J |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Turkish Thoracic Society
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7020889/ https://ncbi.nlm.nih.gov/pubmed/32163366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/TurkThoracJ.2019.180204 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|